Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review

Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eigh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurosurgery 1993-12, Vol.33 (6), p.964-971
Hauptverfasser: Hoffman, H J, Soloniuk, D S, Humphreys, R P, Drake, J M, Becker, L E, De Lima, B O, Piatt, Jr, J H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 971
container_issue 6
container_start_page 964
container_title Neurosurgery
container_volume 33
creator Hoffman, H J
Soloniuk, D S
Humphreys, R P
Drake, J M
Becker, L E
De Lima, B O
Piatt, Jr, J H
description Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.
doi_str_mv 10.1227/00006123-199312000-00002
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1227_00006123_199312000_00002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8134009</sourcerecordid><originalsourceid>FETCH-LOGICAL-c224t-6983a2e37f2555059fd77b4b27bfc57e02107218ed32a246ae262b7571a37dec3</originalsourceid><addsrcrecordid>eNo9kE1OwzAQhb0AlVI4ApIvYLDHSZywQxVQpCI2ILGLHHvSGuWnst1WvT0JLZ3N6L2ZNxp9hFDB7wWAeuBDZQIkE0UhBQyKjRZckCkXSc5kkX1fkesQfjgXWaLyCZnkQiacF1Ni3nWnV9hiF6nuLO230fQt0r6mTb9nK68tUh2i780h9q0O4ySukbbONq5D6jpq1q6xHrtHqqnHYTVs0ES3w0HtHO5vyGWtm4C3pz4jXy_Pn_MFW368vs2flswAJJFlRS41oFQ1pGnK06K2SlVJBaqqTaqQg-AKRI5WgoYk0wgZVCpVQktl0cgZyY93zfBC8FiXG-9a7Q-l4OWIqvxHVZ5R_VkwRO-O0c22atGegydO8hcDw2b2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Hoffman, H J ; Soloniuk, D S ; Humphreys, R P ; Drake, J M ; Becker, L E ; De Lima, B O ; Piatt, Jr, J H</creator><creatorcontrib>Hoffman, H J ; Soloniuk, D S ; Humphreys, R P ; Drake, J M ; Becker, L E ; De Lima, B O ; Piatt, Jr, J H</creatorcontrib><description>Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.</description><identifier>ISSN: 0148-396X</identifier><identifier>DOI: 10.1227/00006123-199312000-00002</identifier><identifier>PMID: 8134009</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Antineoplastic Agents - therapeutic use ; Astrocytoma - mortality ; Astrocytoma - therapy ; Brain Neoplasms - mortality ; Brain Neoplasms - therapy ; Brain Stem ; Child ; Child, Preschool ; Combined Modality Therapy ; Cranial Irradiation ; Cranial Nerve Neoplasms - mortality ; Cranial Nerve Neoplasms - therapy ; Female ; Humans ; Hypothalamus ; Infant ; Male ; Neoplasm Recurrence, Local - epidemiology ; Neurofibromatoses - epidemiology ; Optic Chiasm ; Pineal Gland ; Prognosis ; Retrospective Studies ; Thalamus ; Treatment Outcome</subject><ispartof>Neurosurgery, 1993-12, Vol.33 (6), p.964-971</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c224t-6983a2e37f2555059fd77b4b27bfc57e02107218ed32a246ae262b7571a37dec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8134009$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoffman, H J</creatorcontrib><creatorcontrib>Soloniuk, D S</creatorcontrib><creatorcontrib>Humphreys, R P</creatorcontrib><creatorcontrib>Drake, J M</creatorcontrib><creatorcontrib>Becker, L E</creatorcontrib><creatorcontrib>De Lima, B O</creatorcontrib><creatorcontrib>Piatt, Jr, J H</creatorcontrib><title>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</title><title>Neurosurgery</title><addtitle>Neurosurgery</addtitle><description>Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.</description><subject>Adolescent</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Astrocytoma - mortality</subject><subject>Astrocytoma - therapy</subject><subject>Brain Neoplasms - mortality</subject><subject>Brain Neoplasms - therapy</subject><subject>Brain Stem</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Combined Modality Therapy</subject><subject>Cranial Irradiation</subject><subject>Cranial Nerve Neoplasms - mortality</subject><subject>Cranial Nerve Neoplasms - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Hypothalamus</subject><subject>Infant</subject><subject>Male</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neurofibromatoses - epidemiology</subject><subject>Optic Chiasm</subject><subject>Pineal Gland</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Thalamus</subject><subject>Treatment Outcome</subject><issn>0148-396X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1OwzAQhb0AlVI4ApIvYLDHSZywQxVQpCI2ILGLHHvSGuWnst1WvT0JLZ3N6L2ZNxp9hFDB7wWAeuBDZQIkE0UhBQyKjRZckCkXSc5kkX1fkesQfjgXWaLyCZnkQiacF1Ni3nWnV9hiF6nuLO230fQt0r6mTb9nK68tUh2i780h9q0O4ySukbbONq5D6jpq1q6xHrtHqqnHYTVs0ES3w0HtHO5vyGWtm4C3pz4jXy_Pn_MFW368vs2flswAJJFlRS41oFQ1pGnK06K2SlVJBaqqTaqQg-AKRI5WgoYk0wgZVCpVQktl0cgZyY93zfBC8FiXG-9a7Q-l4OWIqvxHVZ5R_VkwRO-O0c22atGegydO8hcDw2b2</recordid><startdate>19931201</startdate><enddate>19931201</enddate><creator>Hoffman, H J</creator><creator>Soloniuk, D S</creator><creator>Humphreys, R P</creator><creator>Drake, J M</creator><creator>Becker, L E</creator><creator>De Lima, B O</creator><creator>Piatt, Jr, J H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19931201</creationdate><title>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</title><author>Hoffman, H J ; Soloniuk, D S ; Humphreys, R P ; Drake, J M ; Becker, L E ; De Lima, B O ; Piatt, Jr, J H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c224t-6983a2e37f2555059fd77b4b27bfc57e02107218ed32a246ae262b7571a37dec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adolescent</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Astrocytoma - mortality</topic><topic>Astrocytoma - therapy</topic><topic>Brain Neoplasms - mortality</topic><topic>Brain Neoplasms - therapy</topic><topic>Brain Stem</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Combined Modality Therapy</topic><topic>Cranial Irradiation</topic><topic>Cranial Nerve Neoplasms - mortality</topic><topic>Cranial Nerve Neoplasms - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Hypothalamus</topic><topic>Infant</topic><topic>Male</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neurofibromatoses - epidemiology</topic><topic>Optic Chiasm</topic><topic>Pineal Gland</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Thalamus</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoffman, H J</creatorcontrib><creatorcontrib>Soloniuk, D S</creatorcontrib><creatorcontrib>Humphreys, R P</creatorcontrib><creatorcontrib>Drake, J M</creatorcontrib><creatorcontrib>Becker, L E</creatorcontrib><creatorcontrib>De Lima, B O</creatorcontrib><creatorcontrib>Piatt, Jr, J H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoffman, H J</au><au>Soloniuk, D S</au><au>Humphreys, R P</au><au>Drake, J M</au><au>Becker, L E</au><au>De Lima, B O</au><au>Piatt, Jr, J H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review</atitle><jtitle>Neurosurgery</jtitle><addtitle>Neurosurgery</addtitle><date>1993-12-01</date><risdate>1993</risdate><volume>33</volume><issue>6</issue><spage>964</spage><epage>971</epage><pages>964-971</pages><issn>0148-396X</issn><abstract>Low-grade astrocytomas of the midline of the brain can be difficult to manage because of their location. To evaluate treatment and outcome, we performed a retrospective study of children with midline low-grade astrocytomas admitted to The Hospital for Sick Children between 1976 and 1991. Eighty-eight children with biopsy-proven low-grade astrocytomas were identified. Forty-three tumors occurred in the optic pathways or hypothalamus, 13 in the thalamus, 7 in the pineal region, 14 in the midbrain, and 11 in the medulla. Patient follow-up ranged from 6 months to 15 years, with a mean of 4 years, 9 months. Overall outcome was related to the extent of resection, histological type, and location. Partial resections were often associated with involution of the tumor. Response to radiation was variable, and serious sequelae were observed. Thirty-three patients experienced recurrence, often with a good response to subsequent surgery; however, 12 of these patients died. The probability of survival was calculated to be 96% at 1 year, 91% at 5, and 80% at 10 years. Our study suggests that resection should be considered in all patients, both at presentation and recurrence.</abstract><cop>United States</cop><pmid>8134009</pmid><doi>10.1227/00006123-199312000-00002</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0148-396X
ispartof Neurosurgery, 1993-12, Vol.33 (6), p.964-971
issn 0148-396X
language eng
recordid cdi_crossref_primary_10_1227_00006123_199312000_00002
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Antineoplastic Agents - therapeutic use
Astrocytoma - mortality
Astrocytoma - therapy
Brain Neoplasms - mortality
Brain Neoplasms - therapy
Brain Stem
Child
Child, Preschool
Combined Modality Therapy
Cranial Irradiation
Cranial Nerve Neoplasms - mortality
Cranial Nerve Neoplasms - therapy
Female
Humans
Hypothalamus
Infant
Male
Neoplasm Recurrence, Local - epidemiology
Neurofibromatoses - epidemiology
Optic Chiasm
Pineal Gland
Prognosis
Retrospective Studies
Thalamus
Treatment Outcome
title Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A05%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20and%20outcome%20of%20low-grade%20astrocytomas%20of%20the%20midline%20in%20children:%20a%20retrospective%20review&rft.jtitle=Neurosurgery&rft.au=Hoffman,%20H%20J&rft.date=1993-12-01&rft.volume=33&rft.issue=6&rft.spage=964&rft.epage=971&rft.pages=964-971&rft.issn=0148-396X&rft_id=info:doi/10.1227/00006123-199312000-00002&rft_dat=%3Cpubmed_cross%3E8134009%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8134009&rfr_iscdi=true